NASDAQ NMS - GLOBAL MARKET · PRQR
-0.53% · -$0.0100 · Vol 558.9K
Market closed · last close 4:00 PM ET · price as of 19:24:45 ET
ProQR Therapeutics NV

ProQR Therapeutics NV

Biotechnology
$1.89
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
PRQR
ProQR Therapeutics NV
Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PRQR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PRQR catalysts
About ProQR Therapeutics NV
Biotechnology
Listed since
2014
Employees
187
Country
NL

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.92
Day high
$1.97
Day low
$1.87
Previous close
$1.90
52W high
$3.05
-38.03% from high
52W low
$1.37
31% of range
Market cap
$264.6M
EPS
$-0.4318
Beta
2.39
Shares out
141.1M
Volume
558.9K
0.50× rel vol
Avg volume
1.1M
VWAP
$1.90
Price history computed in-house
1W
+9.88%
1M
+7.39%
3M
+19.62%
1Y
-12.90%
YTD
-6.44%
SMA 50 $1.69 · above
SMA 200 $1.82 · above
52W position 31%

PRQR overview

Veridion Score
59
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PRQR.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PRQR Form 4 filings
Public disclosures

Congress activity in PRQR

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PRQR in the cached public ledger.

Federal contracts

PRQR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PRQR in this window.
Lobbying spend

PRQR lobbying filings, year to date.

Registered lobbying filings matched to ProQR Therapeutics NV.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PRQR in this window.
Loading news for PRQR
Analyst ratings
Sovereign unlock shows live analyst consensus for PRQR.
Options
Sovereign unlock shows live options positioning for PRQR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.